200 related articles for article (PubMed ID: 37537538)
21. Recent developments in our understanding of how platelet-derived growth factor (PDGF) and its receptors contribute to proliferative vitreoretinopathy.
Lei H; Rheaume MA; Kazlauskas A
Exp Eye Res; 2010 Mar; 90(3):376-81. PubMed ID: 19931527
[TBL] [Abstract][Full Text] [Related]
22. Vascular endothelial growth factor A competitively inhibits platelet-derived growth factor (PDGF)-dependent activation of PDGF receptor and subsequent signaling events and cellular responses.
Pennock S; Kazlauskas A
Mol Cell Biol; 2012 May; 32(10):1955-66. PubMed ID: 22431518
[TBL] [Abstract][Full Text] [Related]
23. Platelet-derived growth factor induced alpha-smooth muscle actin expression by human retinal pigment epithelium cell.
Si Y; Wang J; Guan J; Han Q; Hui Y
J Ocul Pharmacol Ther; 2013 Apr; 29(3):310-8. PubMed ID: 23116162
[TBL] [Abstract][Full Text] [Related]
24. Resveratrol inhibits epithelial-mesenchymal transition of retinal pigment epithelium and development of proliferative vitreoretinopathy.
Ishikawa K; He S; Terasaki H; Nazari H; Zhang H; Spee C; Kannan R; Hinton DR
Sci Rep; 2015 Nov; 5():16386. PubMed ID: 26552368
[TBL] [Abstract][Full Text] [Related]
25. Yes-associated protein is essential for proliferative vitreoretinopathy development via the epithelial-mesenchymal transition in retinal pigment epithelial fibrosis.
Zhang W; Li J
J Cell Mol Med; 2021 Nov; 25(21):10213-10223. PubMed ID: 34598306
[TBL] [Abstract][Full Text] [Related]
26. Soluble EphB4 inhibition of PDGF-induced RPE migration in vitro.
He S; Kumar SR; Zhou P; Krasnoperov V; Ryan SJ; Gill PS; Hinton DR
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):543-52. PubMed ID: 19696168
[TBL] [Abstract][Full Text] [Related]
27. BMP7 antagonizes proliferative vitreoretinopathy through retinal pigment epithelial fibrosis in vivo and in vitro.
Yao H; Ge T; Zhang Y; Li M; Yang S; Li H; Wang F
FASEB J; 2019 Mar; 33(3):3212-3224. PubMed ID: 30383450
[TBL] [Abstract][Full Text] [Related]
28. P38 inhibition reverses TGFβ1 and TNFα-induced contraction in a model of proliferative vitreoretinopathy.
Schiff L; Boles NC; Fernandes M; Nachmani B; Gentile R; Blenkinsop TA
Commun Biol; 2019; 2():162. PubMed ID: 31069271
[TBL] [Abstract][Full Text] [Related]
29. Snail involves in the transforming growth factor β1-mediated epithelial-mesenchymal transition of retinal pigment epithelial cells.
Li H; Wang H; Wang F; Gu Q; Xu X
PLoS One; 2011; 6(8):e23322. PubMed ID: 21853110
[TBL] [Abstract][Full Text] [Related]
30. Long noncoding RNA ERLR mediates epithelial-mesenchymal transition of retinal pigment epithelial cells and promotes experimental proliferative vitreoretinopathy.
Yang S; Li H; Yao H; Zhang Y; Bao H; Wu L; Zhang C; Li M; Feng L; Zhang J; Zheng Z; Xu G; Wang F
Cell Death Differ; 2021 Aug; 28(8):2351-2366. PubMed ID: 33664479
[TBL] [Abstract][Full Text] [Related]
31. Expression of PDGF and their receptors in human retinal pigment epithelial cells and fibroblasts: regulation by TGF-beta.
Nagineni CN; Kutty V; Detrick B; Hooks JJ
J Cell Physiol; 2005 Apr; 203(1):35-43. PubMed ID: 15368539
[TBL] [Abstract][Full Text] [Related]
32. Overexpression p21WAF1/CIP1 in suppressing retinal pigment epithelial cells and progression of proliferative vitreoretinopathy via inhibition CDK2 and cyclin E.
Wang Y; Yuan Z; You C; Han J; Li H; Zhang Z; Yan H
BMC Ophthalmol; 2014 Nov; 14():144. PubMed ID: 25421815
[TBL] [Abstract][Full Text] [Related]
33. NFκB-Mediated Expression of Phosphoinositide 3-Kinase δ Is Critical for Mesenchymal Transition in Retinal Pigment Epithelial Cells.
Han H; Yang Y; Han Z; Wang L; Dong L; Qi H; Liu B; Tian J; Vanhaesebroeck B; Kazlauskas A; Zhang G; Zhang S; Lei H
Cells; 2023 Jan; 12(2):. PubMed ID: 36672142
[TBL] [Abstract][Full Text] [Related]
34. Plasmin is the major protease responsible for processing PDGF-C in the vitreous of patients with proliferative vitreoretinopathy.
Lei H; Velez G; Hovland P; Hirose T; Kazlauskas A
Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):42-8. PubMed ID: 18172073
[TBL] [Abstract][Full Text] [Related]
35. Epithelial-mesenchymal transition suppresses ERas to activate autophagy in retinal pigment epithelial cells in proliferative vitreoretinopathy.
Pan J; Zhao LX
Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4627-4634. PubMed ID: 32432726
[TBL] [Abstract][Full Text] [Related]
36. Nintedanib inhibits normal human vitreous-induced epithelial-mesenchymal transition in human retinal pigment epithelial cells.
Yin Y; Liu S; Liu H; Wu W
Biomed Pharmacother; 2023 Oct; 166():115403. PubMed ID: 37659204
[TBL] [Abstract][Full Text] [Related]
37. Targeting matrix stiffness-induced activation of retinal pigment epithelial cells through the RhoA/YAP pathway ameliorates proliferative vitreoretinopathy.
Zhang W; Han H
Exp Eye Res; 2021 Aug; 209():108677. PubMed ID: 34147507
[TBL] [Abstract][Full Text] [Related]
38. Pathological vitreous causes cell line-derived (but not donor-derived) retinal pigment epithelial cells to display proliferative vitreoretinopathy-like features in culture.
Sharma M; Tiwari A; Sharma S; Bansal R; Gupta V; Gupta A; Luthra-Guptasarma M
Clin Exp Ophthalmol; 2014 Nov; 42(8):745-60. PubMed ID: 24612444
[TBL] [Abstract][Full Text] [Related]
39. The role of thrombin in proliferative vitreoretinopathy.
Bastiaans J; van Meurs JC; Mulder VC; Nagtzaam NM; Smits-te Nijenhuis M; Dufour-van den Goorbergh DC; van Hagen PM; Hooijkaas H; Dik WA
Invest Ophthalmol Vis Sci; 2014 Jul; 55(7):4659-66. PubMed ID: 25015355
[TBL] [Abstract][Full Text] [Related]
40. Is neutralizing vitreal growth factors a viable strategy to prevent proliferative vitreoretinopathy?
Pennock S; Haddock LJ; Eliott D; Mukai S; Kazlauskas A
Prog Retin Eye Res; 2014 May; 40():16-34. PubMed ID: 24412519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
